| abstract |
It is within the sea of the present invention to provide a novel therapeutic agent for use in a method for treating cancer, particularly solid cancer. The above problems are solved by providing a combination therapy comprising an anti-hyaluronan agent such as a polymer-bound hyaluronan degrading enzyme and a tumor targeting taxane and optionally an additional chemotherapeutic agent such as a nucleoside analog. [Selection figure] None |